![Bong Koh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bong Koh
Private Equity Investor chez
Venrock Associates
Profil
Bong Y.
Koh is currently a Partner at Venrock Associates since 2009.
He previously held positions as Director at Adverum Biotechnologies, Inc., Independent Director at Novartis Gene Therapies, Inc., Managing Director at Phyto Partners LLC, Independent Director at Artiva Biotherapeutics, Inc., and Director at Rayzebio, Inc. He also worked as an Analyst at Sigma Capital Management LLC in 2009, and as a Principal at The Boston Consulting Group, Inc., TVM Capital Corp., Venrock Healthcare Capital Partners LP, and Surveyor Capital Ltd. Dr. Koh received his undergraduate degree from Yale University, his doctorate from The University of California, San Francisco, and his MBA from Harvard Business School.
Postes actifs de Bong Koh
| Sociétés | Poste | Début |
|---|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Private Equity Investor | 01/01/2009 |
Anciens postes connus de Bong Koh
| Sociétés | Poste | Fin |
|---|---|---|
| AVEXIS INC | Directeur/Membre du Conseil | 14/05/2018 |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Corporate Officer/Principal | 31/03/2011 |
Sigma Capital Management LLC
 Sigma Capital Management LLC Investment ManagersFinance Sigma Capital Management is a global, multi-cap long/short investor. | Analyst-Equity | 30/06/2009 |
Venrock Healthcare Capital Partners LP
 Venrock Healthcare Capital Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
| ARTIVA BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Bong Koh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Sigma Capital Management LLC
Sigma Capital Management LLC Investment ManagersFinance Sigma Capital Management is a global, multi-cap long/short investor. | Finance |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TVM Capital Corp.
 TVM Capital Corp. Investment ManagersFinance TVM Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in earlystage capital requirements. | Finance |
Venrock Healthcare Capital Partners LP
Venrock Healthcare Capital Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Surveyor Capital Ltd.
Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Miscellaneous |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Phyto Partners LLC
 Phyto Partners LLC Investment ManagersFinance Phyto Partners invests in companies located in the United States. The firm focuses on education, branded products, agriculture technology, sale software and biotechnology sectors. It participates in early stage capital transactions. | Finance |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Choisissez Zonebourse 
